Daiichi Sankyo (OTCMKTS:DSNKY) Sets New 1-Year Low – Time to Sell?

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKYGet Free Report) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $22.44 and last traded at $22.91, with a volume of 372139 shares trading hands. The stock had previously closed at $23.90.

Daiichi Sankyo Trading Down 4.1 %

The company has a debt-to-equity ratio of 0.06, a current ratio of 2.77 and a quick ratio of 2.11. The stock’s 50 day moving average is $24.44 and its 200-day moving average is $28.32. The company has a market capitalization of $43.72 billion and a P/E ratio of 26.64.

Daiichi Sankyo (OTCMKTS:DSNKYGet Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.22 earnings per share (EPS) for the quarter. Daiichi Sankyo had a return on equity of 14.53% and a net margin of 13.62%. As a group, equities research analysts anticipate that Daiichi Sankyo Company, Limited will post 0.73 earnings per share for the current year.

Daiichi Sankyo Company Profile

(Get Free Report)

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.

Featured Articles

Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.